Julia Aniscenko

Julia Aniscenko

Auto-generated profile, based on publicly available information

Julia Aniscenko

Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2016 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
NGNicholas Glanville
Nicholas Glanville
TPTamlyn J. Peel
Tamlyn J. Peel
ASArmin Schröder
Armin Schröder
JAJulia Aniscenko
Julia Aniscenko
RWRoss P. Walton
Ross P. Walton
SJSebastian L Johnston
Sebastian L Johnston
Current understanding of adaptive immune, particularly T cell, responses to human rhinoviruses (RV) is limited. Memory T cells are thought to be of a primarily T helper 1 type, but both T helper 1 and T helper 2 memory cells have been described, and heightened T helper 2/ lessened T helper 1 responses have been associated with increased RV-induced asthma exacerbation severity. We examined the contribution of T helper 1 cells to RV-induced airways inflammation using mice deficient in the transcription factor T-Box Expressed In T Cells (Tbet), a critical controller of T helper 1 cell differentiation. Using flow cytometry we showed that Tbet deficient mice lacked the T helper 1 response of wild type mice and instead developed mixed T helper 2/T helper 17 responses to RV infection, evidenced by increased numbers of GATA binding protein 3 (GATA-3) and RAR-related orphan receptor gamma t (RORγt), and interleukin-13 and interleukin-17A expressing CD4+ T cells in the lung. Forkhead box P3 (FOXP3) and interleukin-10 expressing T cell numbers were unaffected. Tbet deficient mice also displayed deficiencies in lung Natural Killer, Natural Killer T cell and γδT cell responses, and serum neutralising antibody responses. Tbet deficient mice exhibited pronounced airways eosinophilia and mucus production in response to RV infection that, by utilising a CD4+ cell depleting antibody, were found to be T helper cell dependent. RV induction of T helper 2 and T helper 17 responses may therefore have an important role in directly driving features of allergic airways disease such as eosinophilia and mucus hypersecretion during asthma exacerbations. Rhinovirus infections cause the common cold and a high proportion of exacerbations of asthma and chronic obstructive airway disease. Little is understood of the roles of T cells in causing or limiting rhinovirus disease. Rhinovirus-specific memory cells are primarily of a T helper 1 type in healthy people, but rhinovirus-specific T helper 2 cells have been detected in blood of asthmatics. We examined the role of T helper 1 cells in rhinovirus disease using a mouse strain deficient in a key T helper 1 associated transcription factor. We show that mice deficient in T helper 1 cells instead develop a mixed T helper 2 and T helper 17 response to rhinovirus that was associated with a lack of neutralising antibody response and development of airway eosinophilia and mucus secretion, features of allergic asthmatic airways inflammation. Our study therefore provides new insight into how the nature of the rhinovirus-specific T helper cell response could influence rhinovirus-induced airways disease, especially in asthma, as well as generation of protective immunity.

1 April 2019 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
MCMaria Adelaide Calderazzo
Maria Adelaide Calderazzo
MTMaria-Belen Trujillo-Torralbo
Maria-Belen Trujillo-Torralbo
LFLydia Joanne Finney
Lydia Joanne Finney
ASAran Singanayagam
Aran Singanayagam
EBEteri Bakhsoliani
Eteri Bakhsoliani
PMPatrick Mallia
Patrick Mallia
Purpose: COPD patients often do not report acute exacerbations to healthcare providers – unreported exacerbations. It is not known whether variances in symptoms, airway obstruction, aetiology and inflammatory responses account for differences in reporting of COPD exacerbations. The aims of the study were to compare symptoms, lung function changes, aetiology and inflammatory markers between exacerbations that were reported to healthcare providers or treated, with those that were unreported and untreated. Patients and methods: We recruited a cohort of COPD patients and collected clinical data and blood and airway samples when stable and during acute exacerbations. Virological and bacterial analyses were carried out and inflammatory markers measured. Results: We found no differences in symptoms, lung function, incidence of infection and inflammatory markers between reported and unreported exacerbations. Subjects who reported all exacerbations had higher BODE scores, lower FEV1 and more exacerbations compared with those who did not. Conclusion: The failure to report exacerbations is not related to the severity, aetiology or inflammatory profile of the exacerbation. Patients with less severe COPD and less frequent exacerbations are less likely to report exacerbations. The decision to report an exacerbation is not an objective marker of exacerbation severity and therefore studies that do not count unreported exacerbations will underestimate the frequency of clinically significant exacerbations. A better understanding of the factors that determine non-reporting of exacerbations is required to improve exacerbation reporting. Trial registration: ClinicalTrials.gov Identifier: NCT01376830. Registered June 17, 2011

18 November 2025 in bioRxiv
Verified
Preprint
Open access
FFFaith Fore
Faith Fore
DBDustin Bagley
Dustin Bagley
RMRocio Teresa Martinez-Nunez
Rocio Teresa Martinez-Nunez
JAJulia Aniscenko
Julia Aniscenko
SJSebastian L Johnston
Sebastian L Johnston
JRJody Rosenblatt
Jody Rosenblatt
Epithelial barriers represent the first line of defence against pathogens, yet their role in innate immunity is typ-ically relegated to pathogen detection and immune cell recruitment. This perspective ignores a fundamental evolutionary principle: epithelia defended against pathogens long before complex immune systems evolved. Here, we demonstrate that human bronchial epithelial monolayers retain this ancestral capacity, autono-mously clearing rhinovirus (RV) within 24 hours by selectively extruding infected cells—a process we term virus-induced cell extrusion (VICE). VICE occurs in two waves: a rapid response occurring independently of virus entry, followed by a replication-dependent wave. Barrier-defective epithelia that cannot extrude fail to clear RV. While extrusion maintains barrier integrity and eliminates local infection, it also expels virus-laden cells, promoting transmission. Thus, VICE enables leukocyte-independent epithelial defence while inadver-tently promoting viral transmission, reflecting an evolutionary strategy that prioritizes barrier integrity over containment. These findings redefine epithelia as central players in viral pathogenesis and host protection.

25 September 2026 in Science Advances
Verified
Journal Article
Open access
FFFaith Fore
Faith Fore
DBDustin C. Bagley
Dustin C. Bagley
RMRocio Teresa Martinez-Nunez
Rocio Teresa Martinez-Nunez
JAJulia Aniscenko
Julia Aniscenko
SJSebastian L Johnston
Sebastian L Johnston
JRJody Rosenblatt
Jody Rosenblatt
Epithelial barriers represent the first line of defense against pathogens, yet their role in innate immunity is typically relegated to pathogen detection and immune cell recruitment. This perspective ignores a fundamental biological principle: Epithelia defended against pathogens long before complex immune systems evolved. Here, we demonstrate that human bronchial epithelium retains this ancestral capacity, autonomously clearing rhinovirus (RV) within 24 hours by selectively extruding infected cells, a process that we term virus-induced cell extrusion (VICE). VICE occurs in two waves: a rapid response occurring independently of complete virus entry, followed by a replication-dependent wave. Barrier-defective epithelia that cannot extrude do not eliminate RV. While VICE maintains barrier integrity and reduces local infection, it also expels virus-laden cells, which can infect fresh epithelia. Thus, VICE enables leukocyte-independent epithelial defense while inadvertently promoting viral spread, redefining epithelia as central to viral pathogenesis and host protection.